0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Powerful Analgesics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-5H10152
Home | Market Reports | Health| Health Conditions| Pain Management
Global Powerful Analgesics Market Research Report 2022
BUY CHAPTERS

Powerful Analgesics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5H10152
Report
December 2024
Pages:160
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Powerful Analgesics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Powerful Analgesics - Market

Powerful Analgesics - Market

Powerful analgesics are medications used to treat severe or long-term (chronic) pain.
The global market for Powerful Analgesics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Powerful Analgesics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Powerful Analgesics by region & country, by Type, and by Application.
The Powerful Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Powerful Analgesics.
Market Segmentation

Scope of Powerful Analgesics - Market Report

Report Metric Details
Report Name Powerful Analgesics - Market
CAGR 5%
Segment by Type:
  • Morphine
  • Hydromorphone
  • Oxymorphone
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Teva, KV Pharmaceutical, Lannett, Apotex, Fresenius, Johnson and Johnson, Mundipharma, Novartis, Stada Arzneimittel, Mylan, Endo Pharmaceuticals, Sun Pharmaceutical Industries, Northeast Pharmaceutical Group, Shandong Keyuan Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Powerful Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Powerful Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Powerful Analgesics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Powerful Analgesics - Market report?

Ans: The main players in the Powerful Analgesics - Market are Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Teva, KV Pharmaceutical, Lannett, Apotex, Fresenius, Johnson and Johnson, Mundipharma, Novartis, Stada Arzneimittel, Mylan, Endo Pharmaceuticals, Sun Pharmaceutical Industries, Northeast Pharmaceutical Group, Shandong Keyuan Pharmaceutical

What are the Application segmentation covered in the Powerful Analgesics - Market report?

Ans: The Applications covered in the Powerful Analgesics - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Powerful Analgesics - Market report?

Ans: The Types covered in the Powerful Analgesics - Market report are Morphine, Hydromorphone, Oxymorphone, Others

1 Market Overview
1.1 Powerful Analgesics Product Introduction
1.2 Global Powerful Analgesics Market Size Forecast
1.2.1 Global Powerful Analgesics Sales Value (2019-2030)
1.2.2 Global Powerful Analgesics Sales Volume (2019-2030)
1.2.3 Global Powerful Analgesics Sales Price (2019-2030)
1.3 Powerful Analgesics Market Trends & Drivers
1.3.1 Powerful Analgesics Industry Trends
1.3.2 Powerful Analgesics Market Drivers & Opportunity
1.3.3 Powerful Analgesics Market Challenges
1.3.4 Powerful Analgesics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Powerful Analgesics Players Revenue Ranking (2023)
2.2 Global Powerful Analgesics Revenue by Company (2019-2024)
2.3 Global Powerful Analgesics Players Sales Volume Ranking (2023)
2.4 Global Powerful Analgesics Sales Volume by Company Players (2019-2024)
2.5 Global Powerful Analgesics Average Price by Company (2019-2024)
2.6 Key Manufacturers Powerful Analgesics Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Powerful Analgesics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Powerful Analgesics
2.9 Powerful Analgesics Market Competitive Analysis
2.9.1 Powerful Analgesics Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Powerful Analgesics Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powerful Analgesics as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Morphine
3.1.2 Hydromorphone
3.1.3 Oxymorphone
3.1.4 Others
3.2 Global Powerful Analgesics Sales Value by Type
3.2.1 Global Powerful Analgesics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Powerful Analgesics Sales Value, by Type (2019-2030)
3.2.3 Global Powerful Analgesics Sales Value, by Type (%) (2019-2030)
3.3 Global Powerful Analgesics Sales Volume by Type
3.3.1 Global Powerful Analgesics Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Powerful Analgesics Sales Volume, by Type (2019-2030)
3.3.3 Global Powerful Analgesics Sales Volume, by Type (%) (2019-2030)
3.4 Global Powerful Analgesics Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Powerful Analgesics Sales Value by Application
4.2.1 Global Powerful Analgesics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Powerful Analgesics Sales Value, by Application (2019-2030)
4.2.3 Global Powerful Analgesics Sales Value, by Application (%) (2019-2030)
4.3 Global Powerful Analgesics Sales Volume by Application
4.3.1 Global Powerful Analgesics Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Powerful Analgesics Sales Volume, by Application (2019-2030)
4.3.3 Global Powerful Analgesics Sales Volume, by Application (%) (2019-2030)
4.4 Global Powerful Analgesics Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Powerful Analgesics Sales Value by Region
5.1.1 Global Powerful Analgesics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Powerful Analgesics Sales Value by Region (2019-2024)
5.1.3 Global Powerful Analgesics Sales Value by Region (2025-2030)
5.1.4 Global Powerful Analgesics Sales Value by Region (%), (2019-2030)
5.2 Global Powerful Analgesics Sales Volume by Region
5.2.1 Global Powerful Analgesics Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Powerful Analgesics Sales Volume by Region (2019-2024)
5.2.3 Global Powerful Analgesics Sales Volume by Region (2025-2030)
5.2.4 Global Powerful Analgesics Sales Volume by Region (%), (2019-2030)
5.3 Global Powerful Analgesics Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Powerful Analgesics Sales Value, 2019-2030
5.4.2 North America Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Powerful Analgesics Sales Value, 2019-2030
5.5.2 Europe Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Powerful Analgesics Sales Value, 2019-2030
5.6.2 Asia Pacific Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Powerful Analgesics Sales Value, 2019-2030
5.7.2 South America Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Powerful Analgesics Sales Value, 2019-2030
5.8.2 Middle East & Africa Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Powerful Analgesics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Powerful Analgesics Sales Value
6.2.1 Key Countries/Regions Powerful Analgesics Sales Value, 2019-2030
6.2.2 Key Countries/Regions Powerful Analgesics Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Powerful Analgesics Sales Value, 2019-2030
6.3.2 United States Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Powerful Analgesics Sales Value, 2019-2030
6.4.2 Europe Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Powerful Analgesics Sales Value, 2019-2030
6.5.2 China Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Powerful Analgesics Sales Value, 2019-2030
6.6.2 Japan Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Powerful Analgesics Sales Value, 2019-2030
6.7.2 South Korea Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Powerful Analgesics Sales Value, 2019-2030
6.8.2 Southeast Asia Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Powerful Analgesics Sales Value, 2019-2030
6.9.2 India Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Powerful Analgesics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Company Information
7.1.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
7.1.3 Mallinckrodt Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Mallinckrodt Pharmaceuticals Powerful Analgesics Product Offerings
7.1.5 Mallinckrodt Pharmaceuticals Recent Development
7.2 Alcaliber
7.2.1 Alcaliber Company Information
7.2.2 Alcaliber Introduction and Business Overview
7.2.3 Alcaliber Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alcaliber Powerful Analgesics Product Offerings
7.2.5 Alcaliber Recent Development
7.3 Purdue Pharma
7.3.1 Purdue Pharma Company Information
7.3.2 Purdue Pharma Introduction and Business Overview
7.3.3 Purdue Pharma Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Purdue Pharma Powerful Analgesics Product Offerings
7.3.5 Purdue Pharma Recent Development
7.4 Sanofi Winthrop Industrie
7.4.1 Sanofi Winthrop Industrie Company Information
7.4.2 Sanofi Winthrop Industrie Introduction and Business Overview
7.4.3 Sanofi Winthrop Industrie Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Winthrop Industrie Powerful Analgesics Product Offerings
7.4.5 Sanofi Winthrop Industrie Recent Development
7.5 Macfarlan Smith
7.5.1 Macfarlan Smith Company Information
7.5.2 Macfarlan Smith Introduction and Business Overview
7.5.3 Macfarlan Smith Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Macfarlan Smith Powerful Analgesics Product Offerings
7.5.5 Macfarlan Smith Recent Development
7.6 Akorn
7.6.1 Akorn Company Information
7.6.2 Akorn Introduction and Business Overview
7.6.3 Akorn Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Akorn Powerful Analgesics Product Offerings
7.6.5 Akorn Recent Development
7.7 Barr Pharmaceuticals
7.7.1 Barr Pharmaceuticals Company Information
7.7.2 Barr Pharmaceuticals Introduction and Business Overview
7.7.3 Barr Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Barr Pharmaceuticals Powerful Analgesics Product Offerings
7.7.5 Barr Pharmaceuticals Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Powerful Analgesics Product Offerings
7.8.5 Pfizer Recent Development
7.9 Watson Laboratories
7.9.1 Watson Laboratories Company Information
7.9.2 Watson Laboratories Introduction and Business Overview
7.9.3 Watson Laboratories Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Watson Laboratories Powerful Analgesics Product Offerings
7.9.5 Watson Laboratories Recent Development
7.10 Teva
7.10.1 Teva Company Information
7.10.2 Teva Introduction and Business Overview
7.10.3 Teva Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teva Powerful Analgesics Product Offerings
7.10.5 Teva Recent Development
7.11 KV Pharmaceutical
7.11.1 KV Pharmaceutical Company Information
7.11.2 KV Pharmaceutical Introduction and Business Overview
7.11.3 KV Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.11.4 KV Pharmaceutical Powerful Analgesics Product Offerings
7.11.5 KV Pharmaceutical Recent Development
7.12 Lannett
7.12.1 Lannett Company Information
7.12.2 Lannett Introduction and Business Overview
7.12.3 Lannett Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Lannett Powerful Analgesics Product Offerings
7.12.5 Lannett Recent Development
7.13 Apotex
7.13.1 Apotex Company Information
7.13.2 Apotex Introduction and Business Overview
7.13.3 Apotex Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Apotex Powerful Analgesics Product Offerings
7.13.5 Apotex Recent Development
7.14 Fresenius
7.14.1 Fresenius Company Information
7.14.2 Fresenius Introduction and Business Overview
7.14.3 Fresenius Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Fresenius Powerful Analgesics Product Offerings
7.14.5 Fresenius Recent Development
7.15 Johnson and Johnson
7.15.1 Johnson and Johnson Company Information
7.15.2 Johnson and Johnson Introduction and Business Overview
7.15.3 Johnson and Johnson Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Johnson and Johnson Powerful Analgesics Product Offerings
7.15.5 Johnson and Johnson Recent Development
7.16 Mundipharma
7.16.1 Mundipharma Company Information
7.16.2 Mundipharma Introduction and Business Overview
7.16.3 Mundipharma Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Mundipharma Powerful Analgesics Product Offerings
7.16.5 Mundipharma Recent Development
7.17 Novartis
7.17.1 Novartis Company Information
7.17.2 Novartis Introduction and Business Overview
7.17.3 Novartis Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Novartis Powerful Analgesics Product Offerings
7.17.5 Novartis Recent Development
7.18 Stada Arzneimittel
7.18.1 Stada Arzneimittel Company Information
7.18.2 Stada Arzneimittel Introduction and Business Overview
7.18.3 Stada Arzneimittel Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Stada Arzneimittel Powerful Analgesics Product Offerings
7.18.5 Stada Arzneimittel Recent Development
7.19 Mylan
7.19.1 Mylan Company Information
7.19.2 Mylan Introduction and Business Overview
7.19.3 Mylan Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Mylan Powerful Analgesics Product Offerings
7.19.5 Mylan Recent Development
7.20 Endo Pharmaceuticals
7.20.1 Endo Pharmaceuticals Company Information
7.20.2 Endo Pharmaceuticals Introduction and Business Overview
7.20.3 Endo Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Endo Pharmaceuticals Powerful Analgesics Product Offerings
7.20.5 Endo Pharmaceuticals Recent Development
7.21 Sun Pharmaceutical Industries
7.21.1 Sun Pharmaceutical Industries Company Information
7.21.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.21.3 Sun Pharmaceutical Industries Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Sun Pharmaceutical Industries Powerful Analgesics Product Offerings
7.21.5 Sun Pharmaceutical Industries Recent Development
7.22 Northeast Pharmaceutical Group
7.22.1 Northeast Pharmaceutical Group Company Information
7.22.2 Northeast Pharmaceutical Group Introduction and Business Overview
7.22.3 Northeast Pharmaceutical Group Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Northeast Pharmaceutical Group Powerful Analgesics Product Offerings
7.22.5 Northeast Pharmaceutical Group Recent Development
7.23 Shandong Keyuan Pharmaceutical
7.23.1 Shandong Keyuan Pharmaceutical Company Information
7.23.2 Shandong Keyuan Pharmaceutical Introduction and Business Overview
7.23.3 Shandong Keyuan Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Shandong Keyuan Pharmaceutical Powerful Analgesics Product Offerings
7.23.5 Shandong Keyuan Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Powerful Analgesics Industrial Chain
8.2 Powerful Analgesics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Powerful Analgesics Sales Model
8.5.2 Sales Channel
8.5.3 Powerful Analgesics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Powerful Analgesics Market Trends
    Table 2. Powerful Analgesics Market Drivers & Opportunity
    Table 3. Powerful Analgesics Market Challenges
    Table 4. Powerful Analgesics Market Restraints
    Table 5. Global Powerful Analgesics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Powerful Analgesics Revenue Market Share by Company (2019-2024)
    Table 7. Global Powerful Analgesics Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Powerful Analgesics Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Powerful Analgesics Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Powerful Analgesics Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Powerful Analgesics Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Powerful Analgesics
    Table 13. Global Powerful Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powerful Analgesics as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Powerful Analgesics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Powerful Analgesics Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Powerful Analgesics Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Powerful Analgesics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Powerful Analgesics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Powerful Analgesics Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Powerful Analgesics Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Powerful Analgesics Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Powerful Analgesics Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Powerful Analgesics Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Powerful Analgesics Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Powerful Analgesics Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Powerful Analgesics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Powerful Analgesics Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Powerful Analgesics Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Powerful Analgesics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Powerful Analgesics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Powerful Analgesics Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Powerful Analgesics Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Powerful Analgesics Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Powerful Analgesics Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Powerful Analgesics Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Powerful Analgesics Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Powerful Analgesics Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Powerful Analgesics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Powerful Analgesics Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Powerful Analgesics Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Powerful Analgesics Sales Value by Region (2019-2024) & (%)
    Table 44. Global Powerful Analgesics Sales Value by Region (2025-2030) & (%)
    Table 45. Global Powerful Analgesics Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Powerful Analgesics Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Powerful Analgesics Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Powerful Analgesics Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Powerful Analgesics Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Powerful Analgesics Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Powerful Analgesics Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Powerful Analgesics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Powerful Analgesics Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Powerful Analgesics Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Powerful Analgesics Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Powerful Analgesics Sales Volume, (2025-2030) & (K Units)
    Table 57. Mallinckrodt Pharmaceuticals Company Information
    Table 58. Mallinckrodt Pharmaceuticals Introduction and Business Overview
    Table 59. Mallinckrodt Pharmaceuticals Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Mallinckrodt Pharmaceuticals Powerful Analgesics Product Offerings
    Table 61. Mallinckrodt Pharmaceuticals Recent Development
    Table 62. Alcaliber Company Information
    Table 63. Alcaliber Introduction and Business Overview
    Table 64. Alcaliber Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Alcaliber Powerful Analgesics Product Offerings
    Table 66. Alcaliber Recent Development
    Table 67. Purdue Pharma Company Information
    Table 68. Purdue Pharma Introduction and Business Overview
    Table 69. Purdue Pharma Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Purdue Pharma Powerful Analgesics Product Offerings
    Table 71. Purdue Pharma Recent Development
    Table 72. Sanofi Winthrop Industrie Company Information
    Table 73. Sanofi Winthrop Industrie Introduction and Business Overview
    Table 74. Sanofi Winthrop Industrie Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Sanofi Winthrop Industrie Powerful Analgesics Product Offerings
    Table 76. Sanofi Winthrop Industrie Recent Development
    Table 77. Macfarlan Smith Company Information
    Table 78. Macfarlan Smith Introduction and Business Overview
    Table 79. Macfarlan Smith Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Macfarlan Smith Powerful Analgesics Product Offerings
    Table 81. Macfarlan Smith Recent Development
    Table 82. Akorn Company Information
    Table 83. Akorn Introduction and Business Overview
    Table 84. Akorn Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Akorn Powerful Analgesics Product Offerings
    Table 86. Akorn Recent Development
    Table 87. Barr Pharmaceuticals Company Information
    Table 88. Barr Pharmaceuticals Introduction and Business Overview
    Table 89. Barr Pharmaceuticals Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Barr Pharmaceuticals Powerful Analgesics Product Offerings
    Table 91. Barr Pharmaceuticals Recent Development
    Table 92. Pfizer Company Information
    Table 93. Pfizer Introduction and Business Overview
    Table 94. Pfizer Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Pfizer Powerful Analgesics Product Offerings
    Table 96. Pfizer Recent Development
    Table 97. Watson Laboratories Company Information
    Table 98. Watson Laboratories Introduction and Business Overview
    Table 99. Watson Laboratories Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Watson Laboratories Powerful Analgesics Product Offerings
    Table 101. Watson Laboratories Recent Development
    Table 102. Teva Company Information
    Table 103. Teva Introduction and Business Overview
    Table 104. Teva Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Teva Powerful Analgesics Product Offerings
    Table 106. Teva Recent Development
    Table 107. KV Pharmaceutical Company Information
    Table 108. KV Pharmaceutical Introduction and Business Overview
    Table 109. KV Pharmaceutical Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. KV Pharmaceutical Powerful Analgesics Product Offerings
    Table 111. KV Pharmaceutical Recent Development
    Table 112. Lannett Company Information
    Table 113. Lannett Introduction and Business Overview
    Table 114. Lannett Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Lannett Powerful Analgesics Product Offerings
    Table 116. Lannett Recent Development
    Table 117. Apotex Company Information
    Table 118. Apotex Introduction and Business Overview
    Table 119. Apotex Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Apotex Powerful Analgesics Product Offerings
    Table 121. Apotex Recent Development
    Table 122. Fresenius Company Information
    Table 123. Fresenius Introduction and Business Overview
    Table 124. Fresenius Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Fresenius Powerful Analgesics Product Offerings
    Table 126. Fresenius Recent Development
    Table 127. Johnson and Johnson Company Information
    Table 128. Johnson and Johnson Introduction and Business Overview
    Table 129. Johnson and Johnson Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Johnson and Johnson Powerful Analgesics Product Offerings
    Table 131. Johnson and Johnson Recent Development
    Table 132. Mundipharma Company Information
    Table 133. Mundipharma Introduction and Business Overview
    Table 134. Mundipharma Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Mundipharma Powerful Analgesics Product Offerings
    Table 136. Mundipharma Recent Development
    Table 137. Novartis Company Information
    Table 138. Novartis Introduction and Business Overview
    Table 139. Novartis Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Novartis Powerful Analgesics Product Offerings
    Table 141. Novartis Recent Development
    Table 142. Stada Arzneimittel Company Information
    Table 143. Stada Arzneimittel Introduction and Business Overview
    Table 144. Stada Arzneimittel Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Stada Arzneimittel Powerful Analgesics Product Offerings
    Table 146. Stada Arzneimittel Recent Development
    Table 147. Mylan Company Information
    Table 148. Mylan Introduction and Business Overview
    Table 149. Mylan Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Mylan Powerful Analgesics Product Offerings
    Table 151. Mylan Recent Development
    Table 152. Endo Pharmaceuticals Company Information
    Table 153. Endo Pharmaceuticals Introduction and Business Overview
    Table 154. Endo Pharmaceuticals Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Endo Pharmaceuticals Powerful Analgesics Product Offerings
    Table 156. Endo Pharmaceuticals Recent Development
    Table 157. Sun Pharmaceutical Industries Company Information
    Table 158. Sun Pharmaceutical Industries Introduction and Business Overview
    Table 159. Sun Pharmaceutical Industries Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Sun Pharmaceutical Industries Powerful Analgesics Product Offerings
    Table 161. Sun Pharmaceutical Industries Recent Development
    Table 162. Northeast Pharmaceutical Group Company Information
    Table 163. Northeast Pharmaceutical Group Introduction and Business Overview
    Table 164. Northeast Pharmaceutical Group Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Northeast Pharmaceutical Group Powerful Analgesics Product Offerings
    Table 166. Northeast Pharmaceutical Group Recent Development
    Table 167. Shandong Keyuan Pharmaceutical Company Information
    Table 168. Shandong Keyuan Pharmaceutical Introduction and Business Overview
    Table 169. Shandong Keyuan Pharmaceutical Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Shandong Keyuan Pharmaceutical Powerful Analgesics Product Offerings
    Table 171. Shandong Keyuan Pharmaceutical Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Powerful Analgesics Downstream Customers
    Table 175. Powerful Analgesics Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Powerful Analgesics Product Picture
    Figure 2. Global Powerful Analgesics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Powerful Analgesics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Powerful Analgesics Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Powerful Analgesics Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Powerful Analgesics Report Years Considered
    Figure 7. Global Powerful Analgesics Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Powerful Analgesics Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Powerful Analgesics Revenue in 2023
    Figure 10. Powerful Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Morphine Picture
    Figure 12. Hydromorphone Picture
    Figure 13. Oxymorphone Picture
    Figure 14. Others Picture
    Figure 15. Global Powerful Analgesics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Powerful Analgesics Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Powerful Analgesics Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Powerful Analgesics Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Powerful Analgesics Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Others
    Figure 23. Global Powerful Analgesics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Powerful Analgesics Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Powerful Analgesics Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Powerful Analgesics Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Powerful Analgesics Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Powerful Analgesics Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Powerful Analgesics Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Powerful Analgesics Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Powerful Analgesics Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Powerful Analgesics Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Powerful Analgesics Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Powerful Analgesics Sales Volume (%), (2019-2030)
    Figure 40. United States Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Powerful Analgesics Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Powerful Analgesics Sales Value by Application (%), 2023 VS 2030
    Figure 61. Powerful Analgesics Industrial Chain
    Figure 62. Powerful Analgesics Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS